Pfizer to supply up to 6 mln COVID pills

Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seeks to address worldwide disparities in COVID response.
The company said Paxlovid treatment courses will be available for procurement through Global Fund’s COVID-19 Response Mechanism to 132 low- and middle-income countries this year, subject to local regulatory clearances.
While Paxlovid is widely available in many rich countries, availability has been severely restricted in poorer ones. Pfizer said the supply agreement is part of its strategy to facilitate equitable access to oral COVID treatments.
The company has made a deal with several generic drugmakers to produce its treatment at a lower price for developing countries.